NOLVADEX

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Germany, Ecuador, Estonia, France, Hong Kong, Croatia, Ireland, Italy, Japan, Malta, Mexico, Poland, Singapore, South Africa

Active ingredients

The drug NOLVADEX contains one active pharmaceutical ingredient (API):

1 Tamoxifen UNII 7FRV7310N6 - TAMOXIFEN CITRATE

Tamoxifen is a non-steroidal, triphenylethylene-based drug which displays a complex spectrum of oestrogen antagonist and oestrogen agonist-like pharmacological effects in different tissues. Read about Tamoxifen

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
NOLVADEX D Film-coated tablet	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L02BA01	Tamoxifen	L Antineoplastic and immunomodulating agents → L02 Endocrine therapy → L02B Hormone antagonists and related agents → L02BA Anti-estrogens
Discover more medicines within L02BA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10911G, 1880Y
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 502302802116315, 502302901114310
Country: CA	Health Products and Food Branch	Identifier(s): 02048485
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 02793861
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 675-MEE-0115
Country: EE	Ravimiamet	Identifier(s): 1002665
Country: FR	Base de données publique des médicaments	Identifier(s): 60328432, 61961476
Country: HK	Department of Health Drug Office	Identifier(s): 19529
Country: IE	Health Products Regulatory Authority	Identifier(s): 36927
Country: IT	Agenzia del Farmaco	Identifier(s): 023362039, 023362041
Country: JP	医薬品医療機器総合機構	Identifier(s): 4291003F1163, 4291003F2054
Country: MT	Medicines Authority	Identifier(s): MA046/02101, PI908/19001A
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 90749
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100047984
Country: SG	Health Sciences Authority	Identifier(s): 00794P, 00796P
Country: ZA	Health Products Regulatory Authority	Identifier(s): S/21.12/41